MORE►
Caris Life Sciences
David Spetzler, president of Caris Life Sciences [Image: Caris Life Sciences]
Caris Life Sciences Partners with Moderna To Advance mRNA-Based Cancer Drugs
by Lance Murray | Oct 24, 2023
Irving-based Caris said that via this multiyear agreement, Moderna will leverage Caris’ extensive library of de-identified, multimodal data solutions derived from whole exome sequencing, whole transcriptome sequencing, and protein analyses—along with claims data to improve development strategies for Moderna’s oncology pipeline.
by Lance Murray |
Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Lance Murray |
Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
MORE►
DI People: Optic Gaming, Ziosk, Dr Pepper Keurig, and More Announce Leadership Moves
by Lance Murray | Oct 21, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Advent International, Stellar, Stream Realty Partners, The Citizenry, Sabre Corp., SB Architects, and others.
MORE►
by Lance Murray |
Sep 16, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Jacobs, HF Sinclair and Holly Energy Partners, Caris Life Sciences, Fossil Group, Deloitte, TRG, Invited, Instil Bio, RealPage, Critical Start, Genuine Article, and others.
MORE►
by Alex Edwards |
Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Alex Edwards |
Oct 9, 2020
In this week's roundup of hires and promotions in North Texas, you'll also find news from NuZee, Imaginuity, HudsonLake, ALTO Real Estate Funds, AMN Healthcare, Caris Life Sciences, and more.
MORE►
[Image: sidmay/iStockphoto]
Survey Seeks to Gauge DFW’s Interest in the Life Sciences Sector
by Lance Murray | Dec 19, 2019
Anyone interested in the life sciences sector in Dallas-Fort Worth still has time to take BioLabs' survey to evaluate what might come next for local science startups.
MORE►
by Lance Murray |
Dec 12, 2019
The Genomic Profiling Similarity Score uses over 6,500 mathematical models in a machine learning algorithm to compare molecular characteristics of a patient's tumor against Caris' extensive database.
MORE►
by Lance Murray |
Dec 6, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also read about how Caris Life Sciences is offering a new tool to evaluate hereditary cancer risks.
MORE►
by Alex Edwards |
Aug 20, 2019
The Caris Life Sciences Corporate Park in Irving will increase R&D capabilities with a state-of-the-art precision medicine laboratory, create more than 500 jobs in the region, and help Caris continue to "reinvent cancer care."
MORE►
[Illustration: Nobi Prizue via iStock]
Discovery: UTSW Gets $14M to Recruit Researchers; UTA Professor Studies Brain Injuries
by Lance Murray | May 31, 2019
You’ll also find out about how a UT Dallas professor is trying to speed up transistors for chipmakers, and about how Caris Life Sciences’ new collaboration is developing a cancer diagnostic test in this roundup of research and development activity in North Texas.
MORE►
by Lance Murray |
May 3, 2019
You'll also find out about how the FDA has granted Breakthrough Device status to a new Caris Life Sciences cancer test in this roundup of research and development activity in North Texas.
MORE►
by Payton Potter |
May 2, 2019
Using a patient's molecular makeup, Caris and Pharmatech aim to find the perfect clinical trial for each cancer patient—and enroll them in as little as 10 days.
MORE►
by Lance Murray |
Mar 29, 2019
You'll also find out about Caris Life Sciences' data that shows a novel pathway to treating Non-Hodgkins lymphoma in this roundup of research and development activity in North Texas.
MORE►
